WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004002431) HUMANIZED ANTI-LYMPHOTOYIN BETA RECEPTOR ANTIBODIES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/002431    International Application No.:    PCT/US2003/020762
Publication Date: 08.01.2004 International Filing Date: 01.07.2003
Chapter 2 Demand Filed:    29.01.2004    
IPC:
C07K 16/28 (2006.01)
Applicants: BIOGEN, INC. [US/US]; 14 Cambridge Center, Cambridge, MA 02142 (US) (For All Designated States Except US).
GARBER, Ellen [US/US]; (US) (For US Only).
SIMON, Kenneth [US/US]; (US) (For US Only).
SALDANHA, Jose [GB/GB]; (GB) (For US Only)
Inventors: GARBER, Ellen; (US).
SIMON, Kenneth; (US).
SALDANHA, Jose; (GB)
Agent: MANDRAGOURAS, Amy, E.; Lahive & Cockfield, LLP, 28 State Street, Boston, MA 02109 (US)
Priority Data:
60/392,993 01.07.2002 US
60/417,372 09.10.2002 US
Title (EN) HUMANIZED ANTI-LYMPHOTOYIN BETA RECEPTOR ANTIBODIES
(FR) ANTICORPS HUMANISES DIRIGES CONTRE LE RECEPTEUR DE LA LYMPHOTOXINE BETA
Abstract: front page image
(EN)This invention concerns humanized antibodies specific for the lymphotoxin beta receptor (LT-&bgr;-R), cell lines that produce these antibodies, immunochemicals made from the antibodies, and diagnostic methods that use the antibodies. The invention also relates to the use of the antibodies alone or in combination with chemotherapeutic agent(s) in therapeutic methods.
(FR)Cette invention concerne des anticorps humanisés spécifiques du récepteur de la lymphotoxine bêta (LT-?-R), des lignées cellulaires produisant ces anticorps, des produits immunochimiques fabriqués à partir de ces anticorps, et des méthodes diagnostiques utilisant ces anticorps. L'invention concerne également l'utilisation d'anticorps seuls ou en association avec un (des) agent(s) chimiothérapeutique(s) dans des méthodes thérapeutiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)